Company / Operating Income
INTERPACE BIOSCIENCES, INC. Operating Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
$4.1M
FY2025
5-year range
-$6.3M / $8.1M
FY2021-FY2025
Trend
-49.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income has fluctuated over the past 10 years, ranging from -$26M in FY2019 to $8M in FY2024.
Based on SEC 10-K filings.
$4M in FY2025.
Improved from $2M to $4M over the past 2 years.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income decreased 49.6% year-over-year.
- Peak operating income was recorded in FY2024.
- Lowest operating income in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score -2.84 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.1M | -49.6% |
| FY2024 | $8.1M | +294.5% |
| FY2023 | $2.1M | +156.8% |
| FY2022 | -$3.6M | +42.9% |
| FY2021 | -$6.3M | +75.7% |
| FY2020 | -$26.1M | +1.4% |
| FY2019 | -$26.4M | -118.1% |
| FY2018 | -$12.1M | -92.6% |
| FY2017 | -$6.3M | +2.3% |
| FY2016 | -$6.4M | +84.1% |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026